Showing results (191-200 of 376) with videos related to
Sort By:
Pageof 38
Heart (British Cardiac Society)|March 5, 2016
Physical activity in the prevention of coronary heart disease: implications for the clinicianTina Varghese, William M Schultz, Andrew A McCue, et al.Journal of the American Heart Association|November 9, 2020
Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among US Adults: Trends From 2008 to 2017, the Medical Expenditure Panel SurveyVictor Okunrintemi, Martin Tibuakuu, Salim S Virani, et al.Journal of Cardiopulmonary Rehabilitation and Prevention|November 1, 2016
Multicenter Study of Temporal Trends in the Achievement of Atherosclerotic Cardiovascular Disease Risk Factor Goals During Cardiac RehabilitationNeil F Gordon, Richard D Salmon, Laurence S Sperling, et al.European Journal of Preventive Cardiology|November 28, 2024
Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a)Alexander C Razavi, Mikaila P Reyes, John T Wilkins, et al.The New England Journal of Medicine|March 26, 1992
A survey of zidovudine use in pregnant women with human immunodeficiency virus infectionR S Sperling, P Stratton, M J O'Sullivan, et al.American Journal of Preventive Cardiology|April 29, 2024
Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular diseaseDanh Q Nguyen, Neil Keshvani, Alvin Chandra, et al.Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trialMark H Einstein, Peter Takacs, Archana Chatterjee, et al.The Journal of Infectious Diseases|August 11, 1998
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 TeamM Mirochnick, T Fenton, P Gagnier, et al.Expert Opinion on Drug Safety|October 31, 2023
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myelomaShonali Midha, Monique A Hartley-Brown, Clifton C Mo, et al.The Journal of Thoracic and Cardiovascular Surgery|August 2, 2001
Prediction of safe duration of hypothermic circulatory arrest by near-infrared spectroscopyT Sakamoto, S Hatsuoka, U A Stock, et al.Pageof 38